Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Halozyme Therapeutics Insider Sold Shares Worth $6,000,686, According to a Recent SEC Filing

Halozyme Therapeutics Insider Sold Shares Worth $6,000,686, According to a Recent SEC Filing

MT newswireMT newswire2026/11/17 07:45
03:45 AM EST, 11/17/2026 (MT Newswires) -- Helen Torley, Director, President, Chief Executive Officer, on November 12, 2026, sold 60,000 shares in Halozyme Therapeutics (HALO) for $6,000,686. Following the Form 4 filing with the SEC, Torley has control over a total of 767,780 common shares of the company, with 767,780 shares held directly. The sales reported were made pursuant to a trading plan adopted by the reporting person on Dec. 3, 2025 in accordance with Rule 10b5-1. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000115903626000147/xslF345X05/wk-form4_1794879236.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!